Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027066 (
myoclonus
)
4,275
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Corticobasal syndrome (CBS) is a clinical syndrome presenting with progressive asymmetric bradykinesia, rigidity, and dystonia accompanied by cortical signs, such as apraxia, alien limb phenomena, cortical sensory loss,
myoclonus
, and mirror movements. CBS is associated with different pathological conditions including
FTLD
-tau (corticobasal degeneration, CBD; progressive supranuclear palsy, PSP: and Pick disease),
FTLD
-TDP, Alzheimer disease, Creutzfeldt-Jakob disease, and Parkinson disease/dementia with Lewy bodies. Among these, the most common pathology is CBD. In patients with familial and sporadic
FTLD
, MAPT, GRN and C9orf72 mutations are the three main causes of the disease, even though the C9orf72 mutation is rare in Japan. Patients with MAPT mutations present with
FTLD
-tau, and patients with GRN and C9orf72 mutations exhibit
FTLD
-TDP.
FTLD
is also associated with VCP, CHMP2B, TARDBP and FUS mutations, but each of these account for <1% of familial
FTLD
cases. In sporadic cases, the H1c haplotype and the rare p.A152T variant of MAPT are known to be associated with
FTLD
-tau, and the common genetic variant (rs5848) in the 3'-UTR of GRN is associated with
FTLD
-TDP. A recent genome-wide association study identified TMEM106B as a potential risk-modifying factor for
FTLD
-TDP, and STX6, EIF2AK3 and MOBP, for PSP. Despite major advances in genetic studies in recent years, the majority of sporadic CBS cases are genetically unsolved. Further studies are needed to unveil the genetic background of CBS. In this review, we discuss the recent advances related to the genetics of CBS, particularly about the genetics of
FTLD
.
...
PMID:[The genetics of corticobasal syndrome]. 2330 Jan
Less than 10% of Alzheimer's disease (AD) cases are familial.
Presenilin-1
(
PSEN1
) mutations are the most frequent aetiology and may be associated to atypical neurological manifestations. We report the case of a 27-year-old right-handed man, ensuing with mild cognitive impairment, motor discoordination and axial
myoclonus
after a parachute accident. At age 32 he was referred to our neurology clinic, presenting cognitive impairment, cerebellar syndrome, axial
myoclonus
and hypomimia, without other signs of parkinsonism. Because of absence of family history, he was worked up along the line of spinal ataxic disorders. Later, he developed pseudobulbar affect, cognitive deterioration, right upper limb paresis and spastic paraparesis. Subsequent investigation identified a
PSEN1
P117L mutation and the diagnosis of autosomal dominant AD was made. This case illustrates the diagnostic challenge imposed by atypical presentation of de novo
PSEN1
mutation, leading to unnecessary investigation. Genetic study might be essential for defining the diagnosis.
...
PMID:Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation. 3056 37